Summary
Pharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Canadian pharmaceuticals market had total revenues of $20.2bn in 2020, representing a compound annual growth rate (CAGR) of 1.3% between 2016 and 2020.
- The launch of the Biosimilars Initiative in many provinces in Canada is likely to significant impact market growth as physicians are obliged to prescribe this cheaper alternative where possible.
- The Canadian government plans to regulate the cost of prescription drugs to generate savings of $10bn over the next ten years for Canadian citizens. If successful, this could contribute to a slowdown in growth anticipated in the market over the forecast period.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Canada
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Canada
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Canada pharmaceuticals market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the Canada pharmaceuticals market by value in 2020?
- What will be the size of the Canada pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the Canada pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in Canada's pharmaceuticals market?
'
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths and weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What has been the rationale behind recent M&A activity?
7.6. How does government regulation impact leading players?
7.7. What impact is the COVID-19 pandemic having on the market?
8 Company Profiles
8.1. Johnson & Johnson
8.2. Pfizer Inc.
8.3. Apotex, Inc.
8.4. Merck & Co., Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Canada pharmaceuticals market value: $ billion, 2016-20
Table 2: Canada pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: Canada pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: Canada pharmaceuticals market share: % share, by value, 2020
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: Annual Financial Ratios
Table 7: Johnson & Johnson: Key Employees
Table 8: Johnson & Johnson: Key Employees Continued
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: Apotex, Inc.: key facts
Table 14: Apotex, Inc.: Key Employees
Table 15: Merck & Co., Inc.: key facts
Table 16: Merck & Co., Inc.: Annual Financial Ratios
Table 17: Merck & Co., Inc.: Key Employees
Table 18: Merck & Co., Inc.: Key Employees Continued
Table 19: Canada size of population (million), 2016-20
Table 20: Canada gdp (constant 2005 prices, $ billion), 2016-20
Table 21: Canada gdp (current prices, $ billion), 2016-20
Table 22: Canada inflation, 2016-20
Table 23: Canada consumer price index (absolute), 2016-20
Table 24: Canada exchange rate, 2016-20
List of Figures
Figure 1: Canada pharmaceuticals market value: $ billion, 2016-20
Figure 2: Canada pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: Canada pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in Canada, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in Canada, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in Canada, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2020
Figure 10: Canada pharmaceuticals market share: % share, by value, 2020
